Tomonori Oura
Eli Lilly (Japan)(JP)
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes Management and Research, Pancreatic function and diabetes, Pharmacology and Obesity Treatment
Most-Cited Works
- → Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial(2022)197 cited
- → Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes(2010)183 cited
- → Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm(2012)143 cited
- → Single amino acid residue as a functional determinant of rod and cone visual pigments(1997)135 cited
- → Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study(2012)84 cited
- → Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in J apanese patients with type 2 diabetes: a randomized, open‐label, phase III , non‐inferiority study(2015)79 cited
- → The activated transforming growth factor‐beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer(2011)74 cited
- → A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes(2021)58 cited
- → Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan(2017)41 cited
- → Isomer-Specific Interaction of the Retinal Chromophore with Threonine-118 in Rhodopsin(2002)39 cited